Prometheus Research appoints vp of sales

Prometheus Research, a US provider of database software for biomedical researchers and industry, has named Peter Harker as its new vice president of sales.

Prometheus Research, a US provider of database software for biomedical researchers and industry, has named Peter Harker as its new vice president of sales.

Harker takes responsibility for developing and managing sales for the company's Research Informatics biomedical software services and new HTSQL database software for industry.

Prior to joining Prometheus, Harker held a variety of sales roles, most recently as managing director for BondDesk, a provider of software and services for fixed income trading.






You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities

The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and differentiating LGM in the US CDMO market, says CEO Prasad Raje, speaking exclusively to Manufacturing Chemist
Finance

TCI Biotech expands US manufacturing with $26m facility investment

Global biotechnology innovator TCI Biotech announces an investment of approximately $26.225m to expand its existing US manufacturing facility in American Fork, Utah
Finance

Applied Biopharm Consulting secures IP grant to protect AI-driven viral capsid engineering innovations

Irish biotech consultancy Applied Biopharm Consulting has received an IP Start Grant from Enterprise Ireland to develop a formal patent strategy around its AI-powered computational platform for engineered adeno-associated virus vector design
Regulatory

Orphan drug sales to exceed $400bn by 2032, Evaluate report finds

Despite FDA policy shifts and the rise of blockbuster obesity drugs, a new Evaluate report confirms rare disease therapies are on track to claim more than a fifth of all global prescription drug sales within a decade
Manufacturing

Lonza completes transformation to pure-play CDMO with agreement to divest Capsules & Health Ingredients

Sale of CHI business to Lone Star funds marks final step in Lonza’s strategic shift to a focused CDMO model
Digital

Symeres awarded ISO/IEC 27001 certification as pharma clients demand stronger data security

Drug discovery CRDMO Symeres has achieved ISO/IEC 27001 certification for information security management, as rising cybersecurity threats and stricter client due diligence requirements push data protection to the top of the outsourcing agenda
Digital

Chanelle Pharma partners with SAP for expansion of international pharmaceutical manufacturing operations

The pharma company will use SAP's S/4HANA Cloud (private edition) and SAP Business AI to modernise its core finance, manufacturing and supply chain processes
Subscribe now